chrisvoncsefalvay/vaers-outcomes huggingface dataset:
States that she developed a maculopapular rash on both arms and legs.  Rash was nonpuretic. No swelling at site. It is still slightly visible.  States she had no changes in diet, laudry soap, or medications prior to vaccination.
Post vax, the patient developed chicken pox on his buttocks, chest and legs. The patient sought unspecified medical attention. Follow up information from the RN indicated that on 08/11/2000 the patient developed a pruritic rash with 20 erythematous papules and vesicles on his buttocks and both legs. It was reported that subsequently, the patient recovered. No further information is expected.
I developed acute swelling of my knuckles, ankles and knees. Could not type or use hands properly for 4 days. Also experienced intense pain in my side on July 3nd, requiring am ER visit. Was the site of former (5 years ago) shingles outbreak.  Have had intense fatigue
14jun89 pt vax hepta B. pt devel. arthralgia & temp 100 F on 14jun89 & nausea w/ emesis on 16jun89. 17jun89 sx ended. 19jun89 pt had gatorade & apple sauce. 17jun89 pt vax 2nd hepta B. same day pt ex. nauseaw/o emesis.  See worm...
When the administering technician was holding his arm down, as she went to administer the vaccine with the other hand, it slipped out of her hand and grazed his arm. A new vaccine was administered to the patient.
7/26/2021  had insanely heavy menstrual cycle that was soaking pads within an hour (normal is ~4-5 hours). She had cramps that she has never experienced before 7/26 eve and 7/27 daytime.  There were large blood clots present (>> quarter size) 7/26-7/28. Normally only small clots.  First heavy point of 1 hour soaks were 6am-11am on 7/26. Then was medium changing 3-5 hours until 7pm. Then became insanely heavy again until  10pm with pad change out at 2 hours. 7/27 normal medium flow but every hour change outs that night. Other days back to a normal routine of medium and light
Information has been received from a physician concerning a 69 year old male patient who in approximately 2009, 1.5 years ago, was vaccinated with a dose of ZOSTAVAX (Merck). Now, two to three days ago, on approximately 25-MAR-2011, the patient had shingles. Physician was not in group and did not want to provide his address. The patient sought unspecified medical attention. At the time of report the patient's status was unknown. No further information is available.
Mammogram taken on May 3rd at 2 PM.  On May 4th I received notification that there are suspicious areas on my right breast and right underarm.
Booster given greater than 12 hours after vial was punctured; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Booster given greater than 12 hours after vial was punctured) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus, Hypertension, Chronic kidney disease, Atrial fibrillation, Cardiac failure and Drug allergy (Vioxx, morphine, celebrax). Concomitant products included ATORVASTATIN, BACLOFEN, AMIODARONE, CIPROFLOXACIN HYDROCHLORIDE (CIPRO 1A PHARMA), BUMETANIDE (BUMEX) and DOCUSATE SODIUM (COLACE) for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Booster given greater than 12 hours after vial was punctured). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Booster given greater than 12 hours after vial was punctured) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment information was provided. No Concomitant medication was provided.   This case was linked to MOD-2021-416295 (Patient Link).
inappropriate schedule; shingles; Pain in the chest area; Itching; Pain back; Fatigue useless; Pain arm; Rash; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles), CHEST PAIN (Pain in the chest area), FATIGUE (Fatigue useless), PRURITUS (Itching) and VACCINATION SITE PAIN (Pain arm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced RASH (Rash). On 12-Feb-2021, the patient experienced FATIGUE (Fatigue useless), PRURITUS (Itching), VACCINATION SITE PAIN (Pain arm) and BACK PAIN (Pain back). On 26-Feb-2021, the patient experienced HERPES ZOSTER (shingles) and CHEST PAIN (Pain in the chest area). On 08-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule ). On 13-Feb-2021, FATIGUE (Fatigue useless), PRURITUS (Itching), VACCINATION SITE PAIN (Pain arm) and BACK PAIN (Pain back) had resolved. At the time of the report, HERPES ZOSTER (shingles), CHEST PAIN (Pain in the chest area), RASH (Rash) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule ) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information include Lyrica, Steroid pack,Valtrex
I have an EXTREMELY regular period my entire life. After the 2nd shot, I got my period 2 weeks early, and the blood is bright red and heavy, which it hasn't been  for years (I am peri menopausal so my periods of late have been very dark and pretty light, though always like clockwork.)  I read somewhere that people are chalking this up to the stress of getting the vaccine. Let me tell you, this is the least amount of stress I've had for this entire quarantine time. Also, we were lucky enough to have the means to have our food and supplies delivered to us, so this last year was actually less stressful than normal.   (I marked "no" on recovered for item 20 as I am still having my period, which at 4 days is a little longer than usual as well.)
I've been experiencing ear ringing  from ear clogging to buzzing, hissing sounds. First it is started in my left ear after few days of the first doze then the right ear. It started real bad after the second injection. Presently, the clogging ear state has diminished but the buzzing, hissing and cricket alike sounds yet present. This pulsatile emerging sounds of perhaps tinnitus,  disrupts my personal life and to concentrate me at work.
So it happened later when I got home, but I suffered from extreme body and muscle pain, heavy fatigue, severe naseua, a fever at about 100 degrees Fahrenheit, and severe migraines. This continued till about 8 am the next morning when my fever finally broke, and the other symptoms have gradually lessened over the period of today.
Shots were given around 1020 and symptoms started around 1025. Pt stated that she could not see. Pt had a blank stare and was cool, clammy, and diaphoretic. Pt was given 2L oxygen via nasal cannula, ice pack on back of neck, and a lolly pop. Vital signs recorded at 1025 O2 sat: 98%, BP: 91/59, P: 105-20. @ 1030: O2 sat: 100- 2L, P: 94-20. @ 1035 BP: 101/69, P: 94-18, O2 sat: 100-2L. Pts skin color returned to normal and was conversational.
CHIEF COMPLAINT:   Presents to ED w/ diarrhea x 10 days. Pt c/o nothing tasting well to her and she is unable to eat anything. Pt c/o weakness. BP 70/40's by EMS. Pt has appointment today w/ PCP and states "I just couldn't wait".   HISTORY OF PRESENT ILLNESS:     Patient is a 54-year-old female with a past medical history of alcoholism, TBI, ischemic cardiomyopathy, chronic wounds of the right ankle, who presents with a 1 to 2-week history of persistent diarrhea described as watery diarrhea, decreased oral intake and claiming that food does not taste as good for the past 2 days.  Believes it was triggered by eating a steak sandwich 2 weeks ago.  Patient denies any fevers or chills, nausea or vomiting, headache, sore throat, myalgias.  Denies any urinary complaints.  She denies any chest pain or shortness of breath, cough.  Reports generalized weakness and notes that she had an appoint with her primary care physician today but states that she felt unwell enough to go.  Does report some mild generalized, crampy abdominal pain.
tongue is swollen, it itching and burns; tongue is swollen, it itching and burns; tongue is swollen, it itching and burns; chest hurts; Dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101427342 (Pfizer). A 45-year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Oct2021 10:10 (Lot number: 320308D) at the age of 45 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: SWOLLEN TONGUE (non-serious), TONGUE DISCOMFORT (non-serious), TONGUE PRURITUS (non-serious) all with onset 22Oct2021 10:40, outcome "unknown" and all described as "tongue is swollen, it itching and burns"; CHEST PAIN (non-serious) with onset 22Oct2021 10:40, outcome "unknown", described as "chest hurts"; DIZZINESS (non-serious) with onset 22Oct2021 10:40, outcome "unknown", described as "Dizzy". Additional information Prior Vaccinations (within 4 weeks) never had any vaccines other than when she was a child. AE(s) following prior vaccinations was none. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was none. The patient reporting on the Pfizer Covid vaccine and who states she was just forced to take the first dose by her job and now her tongue is swollen, it is itching and burns. Her chest hurts and she feels dizzy. She got the shot about 30 minutes ago and it just started. There was nothing was wrong with her before getting the shot. She wants to report this and know what she is supposed to do. The events did not result in Emergency Room nor Physician Office visit. Relevant Tests was none  No follow-up attempts are possible. No further information is expected.
Patient received 2nd dose vaccine as scheduled. 12 minutes after administration patient complained of nausea and a severe headache. The headache became more intense on the back of her head, and included tingling sensations, and radiated down her neck. Patient also was slow to answer our questions, as she said she felt "funny" . Patient stated that she does get migraines by her eye, but nothing like this. A provider was called in to evaluate patient, and provider advised patient be seen in ER. Patient transferred to ER within building via stretcher. Patient was evaluated, given some IV medications, and ok to discharge to home.
Per patient, he has had a rash at the injection site since 9/26 and complains of it itching. Denies any fever, night sweats, chills, loss of appetite, diarrhea, or nausea and vomiting.
Around 8:30 in the morning of May 18 2021, my mother was not feeling well and had a headache since she got the second dose of the COVID vaccine the previous day on May 17, 2021 at 2:00pm. She decided to take 2 Tylenol pills, 500 mg each. After a few minutes of taking the pills she developed a sever allergic reaction. Her headache pain was increasing and eventually her face started to swell up immensely.  Her body developed a rash and she started to feel itchy. I called 911, and the ambulance said her vitals were okay, however I decided to take her to the clinic here and they gave her another shot in her leg to "block" (as the doctor described) the reaction. Additionally, the doctors there decided to send her to the hospital right away and they did more tests that the Doctor can describe further. She did stay overnight in the hospital, and with the treatments she received, her symptoms have gone down.
Tested positive of COVID-19; Tested positive of COVID-19; This is a spontaneous report from a non-contactable consumer (patient) via the Pfizer sponsored program.  A patient of unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 27Aug2021, as 1st single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 23Sep2021, the patient was sick and tested positive for COVID-19. The patient was asking if they could get the 2nd dose. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a healthcare worker refers to 4 patients of unknown age and gender. Pertinent medical history was unknown. On an unknown date the patients was vaccinated with PNEUMOVAX 23 (lot # K007773, expiry date: 01-MAY-2015, dose, route of administration and anatomical location was unknown). Concomitant medications were unspecified by reporter. On an unknown date the patient experienced injection site reactions of redness, fever and itching at the injection site. The outcome of reactions of redness and itching at the injection site was reported as recovered/resolved. The outcome of fever was unknown. The causality was unknown. No further information was provided. This is one of several reports from the same reporter. Additional information has been requested.
Sore joints; Sore injection site; Large amount Fatigue; Migraine; Headache; Brain fog; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 04May2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 04May2021, the patient experienced sore joints. sore injection site, large amount fatigue, migraine, headache, brain fog, and nausea. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore joints, sore injection site, large amount fatigue, migraine, headache, brain fog, and nausea were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
feeling very tired; headache; Muscle pain; Joint pain; Nausea; feeling unwell like the flu; feeling unwell like the flu/awful; This is a spontaneous report from a contactable consumer (patient herself). A 66-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9261) intramuscularly on 21Jan2021 at single dose in left arm for COVID-19 Immunization. Medical history and Concomitant medications were not reported. It was reported that she wanted to report reaction to Pfizer Covid 19 vaccine. stated she was very tired, headache, muscle pain, joint pain, nausea, feeling unwell like the flu. Was injected on 21Jan2021 and this started on 22Jan2021. stated that it has been awful since then. Is her first shot. Stated that since she had such a bad time with the first one should she get the second one. stated that the outcome of feeling very tired and muscle pain varies and cannot be directly determined. Stated that feeling very tired and muscle pain is ongoing. Treatment was reported as none. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
77 patients received Moderna bivalent booster doses that had undergone a temperature excursion; Poor quality vaccine administered; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered).    This case contains information for the 9th of 77 patients described by the reporter.  No concomitant product was reported. It was reported that the dose was administered to patient before it was known if the vaccine was ok to use after the excursion. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-696122 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-696122:Master case
This 64 year old woman received her 1st dose of Moderna mRNA vaccine on 3/9/21.  No adverse events. On approximately 3/15/21 the injection site began to itch. On 3/16/21 the area surrounding the injection site became red, itchy, and slightly raised. Self-treated with diphenhydramine 25 mg at bedtime for two nights. Reaction resolved within 3 days.
Temp 102.6 while  taking  tylenol, headache  muscle, Hr 140  01/05/21 chills, lightheadedness, 01/06 diarrhea
Under fingernails of left hand all fingers turned purple. This lasted about 10 days. Same thing happened after second shot. It has been 7. days since second dose, still purple. No other effects
Left arm began to swell within hours of injection; by Saturday morning (24 hrs after injection), swelling, mild fever (under 100), lethargy, redness, and pain from shoulder to elbow; upper arm was incredibly hard to the touch, warm, and more than double the size of his right arm, swelling continued to increase despite administering Benadryl and Motrin and applying ice packs beginning Friday afternoon (after consulting with pediatrician Friday afternoon when it began); as of Sunday morning (48 hrs after injection), left arm is still about double the size of his right (swelling has gone down slightly overnight) and child notes it doesn't hurt as much but continues to be lethargic and unable to lift left arm without pain); continuing Benadryl, ice, and Motrin into Sunday. This is the second time the flu shot has caused this reaction (last was in 2019 or 2018, I can't access MyChart records to confirm exactly, but this has happened with the flu shot before), but as child had no adverse reaction to COVID shots, we all thought the last adverse reaction to the flu shot was a fluke and thought it'd be safe to try again.
Delayed cutaneous reaction. (1) An area on the shin of my right leg, approximately 2" wide x 4" long, became swollen, hot, and itchy at about 10:00 p.m. on Sunday 3/14/21 - two days after the vaccine. It resolved during the night. (2) On Day 3 - today 3/15/21 - the lymph nodes in my right armpit, where I had lymph nodes removed during breast cancer surgery in 2019, became swollen and remain so. (3) Swallowing seems a little more difficult, although I can eat and drink with no problem. My throat feels swollen but is pain-free.
pt recvd vax; T 104.2; unconsolable crying for more than 3 hrs;
A physician reported that a 13 month old female received her 2nd Prevnar and the next day, experienced angioedema and hives/urticaria. The child recovered. Angioedema was considered to be "Medically Important". Both the investigator and the medical monitor considered the events to be 'possibly' related to Prevnar administration. Follow up information received 03/09/2001 clarified that the patient did not experience angioedema as originally reported. The patient experienced hives/urticaria only. Therefore, this report has been downgraded to non-serious.
nasal congestion, cough, cold, fever x 7 days; beginning 608 hrs p/shot was given; poss underlying viral type infect; bronchitis-like;
This spontaneous report was received from a healthcare worker (medical assistant) and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions and concomitant therapies was provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot # L025738 and expiration date 14-AUG-2017, lot # L018501 and expiration date 22-JUN-2017, exact doses and route of administration were not reported). No adverse events were reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same source. Additional information has been requested.
Administration of Pfizer booster to a 16 y/o prior to authorization by FDA and CDC
Pt received her first dose of the Moderna COVID19 vaccine. While sitting in observation the pt reported a new onset of headache, nausea, and dizziness. BP 141/108, 120/86. HR 90,86. O2sat 99%. Pt takes Hydrochlorothiazide for BP medication. Pt was evaluated by EMS. Pt signed refusal for transport to the ED and was advised to follow up with her PCP.
A pharmacist reported that a female received an injection of TD and she developed "abnormal" swelling and was hospitalized. No further information was available as of the date of this report.
pt recvd vax 9OCT95 & 4-6hrs later pt coughing & bringing up brown color sputum;pt went to bed 1130PM had diff breathing;then left bed & sat in a chair until 345AM;pt taken to hosp & adm dx pneumonia, emphysema,asthma, bronchitis